Continued impact of pneumococcal conjugate vaccine on carriage in young children

Susan S Huang1, Virginia L Hinrichsen, Abbie E Stevenson

  • 1Division of Infectious Diseases, School of Medicine, University of California, Irvine, Orange, CA 92868, USA. sshuang@partners.org

Pediatrics
|July 1, 2009
PubMed

Insights

The heptavalent pneumococcal conjugate vaccine (PCV7) led to a decrease in vaccine-type Streptococcus pneumoniae carriage in children. Non-vaccine serotypes, particularly 19A and 35B, rapidly replaced them, showing increased penicillin resistance.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Vaccinology

Background:

  • The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced to reduce invasive pneumococcal disease.
  • Understanding serotype and antibiotic resistance shifts in Streptococcus pneumoniae carriage is crucial for public health.
  • The impact of PCV7 on carriage dynamics and risk factors in young children requires ongoing assessment.

Purpose of the Study:

  • To assess serial changes in Streptococcus pneumoniae serotypes and antibiotic resistance in young children.
  • To evaluate if PCV7 altered the risk factors associated with pneumococcal carriage.

Main Methods:

  • Nasopharyngeal specimens were collected from children aged 3 months to <7 years across multiple winter seasons (2000-2007).
  • Antimicrobial susceptibility testing and serotyping were performed on collected Streptococcus pneumoniae isolates.
  • Questionnaire and medical record data were analyzed to identify carriage risk factors.

Main Results:

  • Carriage of non-PCV7 serotypes significantly increased from 15% to 29% between 2000-2001 and 2006-2007.
  • Vaccine serotypes decreased to 3% of carried serotypes by 2006-2007, with serotype 19A becoming highly prevalent.
  • Penicillin nonsusceptibility was noted in high-prevalence serotypes, and traditional carriage predictors persisted.

Conclusions:

  • PCV7 led to the near disappearance of vaccine serotypes in pediatric Streptococcus pneumoniae carriage.
  • Penicillin-nonsusceptible nonvaccine serotypes, especially 19A and 35B, rapidly replaced vaccine types.
  • Established risk factors for pneumococcal carriage, such as childcare attendance, remained unchanged by the vaccine.
Abstract

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Vaccinations01:51

Vaccinations

Overview